Using natural products to block DNA repair in cancer cells
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
This study is looking at how certain natural substances can help make cancer cells more vulnerable to treatments like chemotherapy and radiation by blocking important proteins that help them repair their DNA.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10810722 on NIH RePORTER |
What this research studies
This research investigates how natural products can inhibit specific proteins involved in DNA repair, particularly RAD51 and RAD52, which are crucial for cancer cell survival and resistance to treatments. By targeting these proteins, the study aims to disrupt the DNA repair process in cancer cells, making them more susceptible to therapies like chemotherapy and radiation. The approach involves identifying small molecules that can effectively bind to these proteins and interfere with their function, potentially leading to more effective and less toxic cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that exhibit defects in DNA repair mechanisms, such as those with BRCA1 or BRCA2 mutations.
Not a fit: Patients whose cancers do not rely on RAD51 or RAD52 for survival may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new cancer therapies that are more effective and have fewer side effects.
How similar studies have performed: Other research has shown promise in targeting DNA repair mechanisms in cancer, indicating that this approach could be a viable strategy for developing new treatments.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Spies, Maria — University of Iowa
- Study coordinator: Spies, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.